DOCSLIB.ORG

Heparanase and Vascular Endothelial Growth Factor Expression Is Increased in Hypoxia-Induced Retinal Neovascularization

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Heparanase and Vascular Endothelial Growth Factor Expression Is Increased in Hypoxia-Induced Retinal Neovascularization Retinal Cell Biology Heparanase and Vascular Endothelial Growth Factor Expression Is Increased in Hypoxia-Induced Retinal Neovascularization Jie Hu,1 Xin Song,1 Yi Qing He,2,3 Craig Freeman,3 Christopher R. Parish,3 Ling Yuan,1 Honghua Yu,1 and Shibo Tang1 PURPOSE. Heparanase and VEGF are related closely to angiogenesis etinopathy of prematurity (ROP) is a leading cause of in cancer. The purpose of our study was to evaluate the expression Rchildhood blindness over the world, characterized by and correlation of heparanase and VEGF in hypoxia-induced retinal retinal hypoxia-ischemia and neovascularization.1,2 VEGF, neovascularization. which can be upregulated by hypoxia and ischemia,3,4 is one of the most significant factors involved in retinal diseases METHODS. C57BL/6 oxygen-induced retinopathy (OIR) mice and 5,6 human retinal microvascular endothelial cells (HRECs) were associated with pathologic angiogenesis, including ROP. Logically, anti-VEGF therapy has been used in ROP patients treated with the hypoxia mimetic agent cobalt chloride (CoCl2), 7,8 and in the presence of the heparanase inhibitor phosphomanno- and shown beneficial short-term effects. However, it has pentaose sulfate (Muparfostat, PI-88). Heparanase activity was been shown that direct inhibition of VEGF cannot completely assayed in HRECs, and the expression of heparanase, VEGF protein prevent the formation of new vessels and anti-VEGF therapy requires long-term, repeated administration to decrease the and mRNA were evaluated by immunofluorescence, ELISA, continuous generated VEGF.9 Therefore, it is necessary to find Western blot, and real-time PCR while retinal flat mounts were a way to inhibit the VEGF protein production for better control used to evaluate the area of neovascularization of mice retina. of neovascularization. RESULTS. HREC heparanase activity was increased by treatment A very important step in the process of neovascularization with CoCl2, but was decreased by PI-88. Immunofluorescence is to change the integrity of the extracellular matrix (ECM) and showed that heparanase and VEGF staining was intense in subendothelial basement membrane (BM). Heparanase is an hypoxia-treated HRECs and OIR mice retina, while VEGF staining endo-b-glucuronidase that specifically cleaves heparan sulfate was faint in the normoxia and PI-88–treated ones. Western blot (HS) side chains of HS proteoglycans (HSPGs), which are and real-time PCR results indicated that the expression of essential components of the cell surface and ECM that provide heparanase and VEGF was increased under hypoxic conditions, structural integrity.10 Thus, heparanase is involved directly in and the increase of VEGF was inhibited by PI-88. Retinal flat angiogenesis by degrading HS chains. Degradation of HS side mounts showed that the area of new vessels in retina of OIR mice chains also releases HS-bound angiogenic growth factors, was increased compared to the normoxic mice, and this effect was including FGF-2 and VEGF, and HS fragments, which promote inhibited by PI-88. angiogenic growth factor activity.11 It is known that cells are exposed to hypoxic environment ONCLUSIONS Heparanase is upregulated and associated with the C . 12 VEGF expression in hypoxia-induced retinal diseases. Heparanase in solid tumors. Heparanase activity is upregulated by is involved in hypoxia-induced neovascularization through pro- hypoxia in many tumor cells and overexpression of heparanase correlates with increased VEGF protein and mRNA levels, and moting VEGF expression and may be a new therapeutic target for 13–15 hypoxia-induced neovascularization retinal diseases. (Invest Oph- increased tumor vascularity. These studies suggested a thalmol Vis Sci. 2012;53:6810–6817) DOI:10.1167/iovs.11-9144 correlation between heparanase and hypoxia-induced neovas- cularization in tumors. Therefore, a similar mechanism was hypothesized in which heparanase regulates VEGF mRNA and protein levels, and promotes neovascularization in ROP. In our study, as an initial step toward understanding the pathophys- From the 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China; the iologic conditions of ROP, we examined the regulation of 2Department of Oral and Maxillofacial Surgery, Guanghua School of heparanase and VEGF expression in retina under normoxic, Stomatology, Sun Yat-sen University, Guangzhou, China; and the hypoxic, and hypoxia mimic conditions, and the effect of the 3Department of Immunology, The John Curtin School of Medical heparanase inhibitor, phosphomannopentaose sulfate (Mupar- Research, The Australian National University, Canberra, Australia. fostat, PI-88), on the VEGF expression in vitro and in vivo. Supported by the International Cooperation Project of Guang- dong Province (Grant 2008B050100038), the Fundamental Research Funds of State Key Lab of Ophthalmology, Sun Yat-sen University MATERIALS AND METHODS (Grant 2010C04), and Science and Technology Planning Project of Guangdong Province (Grant 2011B020800005). Human Retinal Microvascular Endothelial Cell Submitted for publication November 23, 2011; revised April 15 and August 12, 2012; accepted August 22, 2012. Culture and Treatment Disclosure: J. Hu,None;X. Song,None;Y.Q. He,None;C. Human eyes were obtained from the Eye Bank of Zhongshan Freeman,None;C.R. Parish,None;L. Yuan,None;H. Yu,None; S. Tang,None Ophthalmic Center of Sun Yat-sen University (Guangzhou, China), Corresponding author: Jie Hu, The State Key Laboratory of within 20 hours postmortem. Donors of all these eyes were healthy Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen Univer- accident victims. All human materials were in compliance with the sity, Guangzhou 510060, China; [email protected] World Medical Association Declaration of Helsinki ethical principles for Investigative Ophthalmology & Visual Science, October 2012, Vol. 53, No. 11 6810 Copyright 2012 The Association for Research in Vision and Ophthalmology, Inc. Downloaded from iovs.arvojournals.org on 09/26/2021 IOVS, October 2012, Vol. 53, No. 11 Heparanase and Retinal Neovascularization 6811 FIGURE 1. Heparanase activity, heparanase and VEGF protein levels in CoCl2-treated HRECs. HRECs were cultured in normal media (control), or treated with CoCl2, CoCl2 þ PI-88, and CoCl2 þ PBS for 24 hours. A heparan sulfate degrading enzyme assay kit was used to determine heparanase activity (A). Western blot analysis was performed to detect heparanase (B) and VEGF (C) protein levels. An ELISA was performed on HRECs treated with CoCl2, or CoCl2 þ PI-88, and CoCl2 þ PBS (D). Data represent the mean 6 SD of three experiments. *P < 0.05 versus control. †P < 0.05 versus CoCl2 or PBS. medical research. The procedures were as described previously.16 sterile PBS, pH 7.4.18 For experimental control, HRECs were grown in Briefly, retinal tissues were isolated from eyes, and digested with 2% normal medium containing PBS. trypsogen and 0.1% collagenase I (Sigma Chemical Co., St. Louis, MO.) for 20 minutes at 378C, then subjected to centrifugation (1000g for 10 Mouse Model of Oxygen-Induced Retinopathy and minutes). The pellet was resuspended in human endothelial serum-free Treatment medium (Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) and 5 ng/mL b-endothelial cell growth factor (b- Experiments were performed on C57BL/6 mice (Laboratory Animal ECGF, Sigma), plated into a 21.5 mm2 culture dish precoated with 5 Center of Zhongshan Ophthalmic Center, Sun Yat-sen University) of both sexes at postnatal day (PD) 17. All experiments were in mg/mL fibronectin (Gibco), and then incubated at 378C with 5% CO . 2 compliance with the ARVO Statement for the Use of Animals in Human retinal microvascular endothelial cells (HRECs) were identified Ophthalmic and Vision Research, and were approved by the Animal by positive staining with anti-VIII factor antibody (Biosynthesis Care Committee of Sun Yat-sen University. The reproducible murine Biotechnology Co., Beijing, China). Only cells at passages 3 to 5 were model of oxygen-induced retinopathy (OIR) has been described used for the experiments. previously.19 Briefly, mice pups with their nursing mothers were HRECs were incubated with normal medium (normal group), 100 exposed to room air between PD 1 and PD 17, using as normal lM cobalt chloride (CoCl2 group), or 100 lM CoCl2 combined with 5 controls (Group 1: normal mice). Mice of the same strain and the same lg/mL heparanase inhibitor PI-88 (PI-88 group; Progen Pharmaceuti- age were exposed to 75% 6 2% oxygen between PD 7 and PD 12, and cals Limited, Brisbane, Australia) for 24 hours.17 PI-88 was dissolved in then returned to room air for 5 days (Group 2: OIR mice). OIR mice Downloaded from iovs.arvojournals.org on 09/26/2021 6812 Hu et al. IOVS, October 2012, Vol. 53, No. 11 FIGURE 2. Confocal microscopy analysis of heparanase and VEGF protein levels in CoCl2-treated HRECs. HRECs were cultured in normal media (control; [A–D]), or treated with CoCl2 (E–H), or with CoCl2 + PI-88 (I–L) for 24 hours. Cells were stained with DAPI (blue;[C, G, K]), and rabbit anti-heparanase (green;[A, E, I]) and mouse anti-VEGF (red;[B, F, J]) antibodies. Low levels of heparanase (A) and VEGF (B) were observed in control HRECs and marked increases in CoCl2-treated cells (E, F). The intense VEGF staining was decreased (J) by PI-88. were injected intraperitoneally with PI-88 at a dose of 25 mg/kg/day dish. Cells were washed with PBS 3 times and fixed in fresh 4% for 5 days from PD 12 to PD 16 (Group 3: OIR mice þ PI-88). A vehicle paraformaldehyde (PFA, pH 7–8) for 10 minutes at room temperature. group received sterile PBS alone from PD 12 to PD 16 (Group 4: OIR Next, HRECs were permeabilized in 0.1% Triton X-100 (Sigma) for 5 mice þ PBS).20,21 Animals were anesthetized with intraperitoneal minutes and blocked with 1% BSA (Sigma) in PBS containing 0.1% injection of 10% chloral hydrate at a dose of 3 mL/kg (Zhongshan Tween 20 (blocking solution) for 60 minutes at room temperature.
Load more

Recommended publications
  • Localization of Heparanase in Esophageal Cancer Cells: Respective Roles in Prognosis and Differentiation
    Laboratory Investigation (2004) 84, 1289–1304 & 2004 USCAP, Inc All rights reserved 0023-6837/04 $30.00 www.laboratoryinvestigation.org Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation Takaomi Ohkawa1, Yoshio Naomoto1, Munenori Takaoka1, Tetsuji Nobuhisa1, Kazuhiro Noma1, Takayuki Motoki1, Toshihiro Murata1, Hirokazu Uetsuka1, Masahiko Kobayashi1, Yasuhiro Shirakawa1, Tomoki Yamatsuji1, Nagahide Matsubara1, Junji Matsuoka1, Minoru Haisa1, Mehmet Gunduz2, Hidetsugu Tsujigiwa2, Hitoshi Nagatsuka2, Masao Hosokawa3, Motowo Nakajima4 and Noriaki Tanaka1 1Department of Gastroenterological Surgery, Transplant, and Surgical Oncology; 2Department of Oral Pathology and Medicine, Graduate School of Medicine and Dentistry, Okayama University, Okayama, Japan; 3Keiyukai Sapporo Hospital, Sapporo, Japan and 4Tsukuba Research Institute, Novartis Pharma KK Tsukuba, Japan In this study, we examined the distribution of heparanase protein in 75 esophageal squamous cell carcinomas by immunohistochemistry and analyzed the relationship between heparanase expression and clinicopatho- logical characteristics. In situ hybridization showed that the mRNA expression pattern of heparanase was similar to that of the protein, suggesting that increased expression of the heparanase protein at the invasive front was caused by an increase of heparanase mRNA in tumor cells. Heparanase expression correlated significantly with depth of tumor invasion, lymph node metastasis, tumor node metastasis (TNM) stage and lymphatic
    [Show full text]
  • Ultrasensitive Small Molecule Fluorogenic Probe for Human Heparanase
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.26.008730; this version posted March 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Ultrasensitive small molecule fluorogenic probe for human heparanase Jun Liu1, 2, Kelton A. Schleyer1, 2, Tyrel L. Bryan2, Changjian Xie2, Gustavo Seabra1, Yongmei Xu3, Arjun Kafle2, Chao Cui1, 2, Ying Wang2, Kunlun Yin2, Benjamin Fetrow2, Paul K. P. Henderson2, Peter Z. Fatland2, Jian Liu3, Chenglong Li1, Hua Guo2, and Lina Cui1, 2, * 1Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA (Current) 2Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, NM 87131, USA 3Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA *Correspondence should be addressed to L.C. E-mail: [email protected] Abstract Heparanase is a critical enzyme involved in the remodeling of the extracellular matrix (ECM), and its elevated expression has been linked with diseases such as cancer and inflammation. The detection of heparanase enzymatic activity holds tremendous value in the study of the cellular microenvironment, and search of molecular therapeutics targeting heparanase, however, assays developed for this enzyme so far have suffered prohibitive drawbacks. Here we present an ultrasensitive fluorogenic small-molecule probe for heparanase enzymatic activity. The probe exhibits a 756-fold fluorescence turn-on response in the presence of human heparanase, allowing one-step detection of heparanase activity in real-time with a picomolar detection limit.
    [Show full text]
  • Heparanase Is Required for Activation and Function of Macrophages
    Heparanase is required for activation and function of macrophages Lilach Gutter-Kapona, Dror Alishekevitzb, Yuval Shakedb, Jin-Ping Lic, Ami Aronheimd, Neta Ilana, and Israel Vlodavskya,1 aCancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel; bDepartment of Cell Biology and Cancer Science, Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel; cDepartment of Medical Biochemistry and Microbiology, University of Uppsala, SE-751 05 Uppsala, Sweden; and dDepartment of Molecular Genetics, the Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel Edited by Joseph Schlessinger, Yale University School of Medicine, New Haven, CT, and approved October 17, 2016 (received for review July 13, 2016) The emerging role of heparanase in tumor initiation, growth, The carcinoma microenvironment includes nontransformed metastasis, and chemoresistance is well recognized and is encouraging epithelial cells, fibroblasts, endothelial cells, and infiltrated immune the development of heparanase inhibitors as anticancer drugs. Unlike cells. Endothelial cells lining blood and lymph vessels are major the function of heparanase in cancer cells, very little attention has component of the tumor microenvironment, and antiangiogenesis been given to heparanase contributed by cells composing the tumor therapy, targeting vascular endothelial growth factor (VEGF) or microenvironment. Here we used a genetic approach and examined its receptor (VEGFR2), is implemented clinically (15). In addi- the behavior and function of macrophages isolated from wild-type tion, recent research has revealed the critical roles of inflam- (WT) and heparanase-knockout (Hpa-KO) mice. Hpa-KO macrophages matory responses in different stages of tumor development and express lower levels of cytokines (e.g., TNFα,IL1-β) and exhibit lower metastasis (16).
    [Show full text]
  • Trevigen Price List 2008 International.Indd
    BASEMENT MEMBRANE EXTRACT PRODUCTS AND SPECIALTY PROTEINS • CELL INVASION ASSAYS • DIRECTED IN VIVO ANGIOGENESIS ASSAYS • COMETASSAYTM • TREVIGEN PAR/PARP/PARG • PRODUCT FOCUS and price list 2008-2009MAY 2008 TACSTM IN SITU APOPTOSIS DETECTION KITS • 1.800.TREVIGEN • www.trevigen.com 2008 TREVIGEN PRODUCT FOCUS AND PRICE LIST Product Overviews BME Tools for 3D Culture Assays TACS™ Basement Membrane Extract Products and 3D Culture Cell Proliferation Assay (96 well) .......10 In Situ Apoptosis Detection Kits .....................18-23 Specialty Proteins ............................................2-5 3D Culture Cell Harvesting Kit ............................11 Annexin DIVAA™ PAR/PARP/PARG For monitoring apoptosis via flow cytometry ...24-25 Directed in vivo Angiogenesis Assays .................6-7 Kits, Reagents, Antibodies, and Enzymes .......12-14 Oxidative Stress Kits Cell Invasion/Migration Assays CometAssay™ ..................................................................26-27 Kits, Reagents, and Plates ................................8-9 Kits, Reagents, and Slides ............................15-17 Trevigen Product International Cell Assays ......................................25 Price List ..........................................28-38 Distributors ..............................39-40 Ordering Information • Please use product names and catalog numbers when ordering. Conditions Trevigen products are sold for Research Use Only. • Please provide your name, purchase order number, shipping address, billing address, and telephone number
    [Show full text]
  • Evidence Against a Role for Heparan Sulfate in Glomerular Permselectivity
    JASN Express. Published on February 14, 2007 as doi: 10.1681/ASN.2007010086 Editorial Breaking Down the Barrier: Evidence against a Role for Heparan Sulfate in Glomerular Permselectivity Scott J. Harvey and Jeffrey H. Miner Renal Division, Washington University School of Medicine, St. Louis, Missouri J Am Soc Nephrol 18: 672–674, 2007. doi: 10.1681/ASN.2007010086 he glomerular capillary wall is thought to function as Charge barrier dysfunction has long been touted as an un- both a size- and charge-selective barrier. The concept of derlying cause of human glomerular disease (10–12). This may T charge selectivity emerged from a series of now classic be brought about by decreased expression or undersulfation of studies that used tracers such as dextran, peroxidase, and fer- GBM-HSPG (13,14). Segmental or global loss of GBM-HS has ritin to evaluate the influence of molecular charge on glomer- been reported in human membranous nephritis, lupus nephri- ular filtration (1–5). The permeability of anionic derivatives of tis, minimal change disease, and diabetic nephropathy (13,15), each tracer was lower than their neutral counterparts of com- as well as in rat models of adriamycin and Heymann nephritis parable size, whereas the permeability of cationic forms was (16,17). The intensity of GBM labeling inversely correlates with enhanced. This led to the theory that the passage of endoge- severity of disease, which supports the theory that reductions nous circulating polyanions, notably albumin, would likewise in GBM-HS contribute directly to a loss of barrier function. be impeded by the “fixed” or intrinsic negative charge of the However, in a recent study, GBM-HS was reported to be nor- glomerular capillary wall.
    [Show full text]
  • Regulation and Function of Heparanase in the Heart
    Regulation and function of heparanase in the heart by FULONG WANG B.Sc., Southeast University, 2009 M.Sc., University of Chinese Academy of Sciences, 2013 A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Pharmaceutical Sciences) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) December 2018 © Fulong Wang, 2018 The following individuals certify that they have read, and recommend to the Faculty of Graduate and Postdoctoral Studies for acceptance, the dissertation entitled: Regulation and function of heparanase in the heart submitted Fulong Wang in partial fulfillment of the requirements by for the Doctor of Philosophy degree of in Pharmaceutical Sciences Examining Committee: Brian Rodrigues, Pharmaceutical Sciences Supervisor Dan Luciani, Faculty of Medicine Supervisory Committee Member Bruce Verchere, Faculty of Medicine Supervisory Committee Member Lucy Marzban University Examiner Angela Devlin University Examiner Additional Supervisory Committee Members: David Granville, Faculty of Medicine Supervisory Committee Member Corey Nislow, Pharmaceutical Sciences Supervisory Committee Member ii Abstract Enzymatically-active heparanase (HepA) has been implicated as an essential metabolic adaptation in the heart following diabetes. However, the regulation of the enzymatically- inactive heparanase (HepL) remain poorly understood. We hypothesized that in response to high glucose (HG) and secretion of HepL from the endothelial cell (EC), HepL uptake and function can protect the cardiomyocyte by modifying its cell death signature. HG promoted both HepL and HepA secretion from EC, with subsequent uptake of HepL into cardiomyocytes. This occurred through a low-density lipoprotein receptor-related protein 1 (LRP1) dependent mechanism, as LRP1 inhibition significantly reduced uptake.
    [Show full text]
  • Extracellular Matrix Degrading Enzymes at the Prostasome Surface
    Prostate Cancer and Prostatic Diseases (2005) 8, 344–348 & 2005 Nature Publishing Group All rights reserved 1365-7852/05 $30.00 www.nature.com/pcan Extracellular matrix degrading enzymes at the prostasome surface I Bellezza1, MC Aisa2, R Palazzo1, E Costanzi1, E Mearini3 & A Minelli1* 1Dipartimento Medicina Sperimentale Scienze Biochimiche, Sezione Biochimica Cellulare, Perugia, Italy; 2Dipartimento Medicina Interna, Sezione Biochimica Applicata Scienze Nutrizionali, Perugia, Italy; and 3Diparimento Specialita` Chirurgiche, Sezione di Urologia, Universita` di Perugia, Perugia, Italia Prostasomes, prostatic secretory vesicles found in human ejaculates, were analyzed to verify the existence at their surfaces of enzymes involved in the degradation of the extracellular matrix. Findings were compared with those of prostasomes isolated from two human adenocarcinoma cell lines that reflect clinical features and molecular pathways of androgen-insensitive and hormone-responsive prostate cancer. Our aim was to determine whether neoplastic transformation is accompanied by changes of glycosidase and protease activities. Our results show that decreases of dipeptidyl peptidase IV and increases of urokinase plasminogen activator and cathepsin B are consistent with the clinical features of the cell lines, whereas increases of glycosidase activities seem to be of scarce biological significance. Prostate Cancer and Prostatic Diseases (2005) 8, 344–348. doi:10.1038/sj.pcan.4500828; published online 30 August 2005 Keywords: PC3; LNCaP; glycosidases; proteases Introduction istics and the presence of saturated and monounsatu- rated fatty acids make the prostasome membrane highly The human prostate gland has a remarkably high ordered and rigid.1 A proteomic analysis has shown the incidence of neoplastic disease and prostate cancer is existence at the prostasome surface of at least 139 one of the most commonly detected male cancers that proteins including enzymes (35%), transport/structural result in a high incidence of mortality.
    [Show full text]
  • Degradation of Heparan Sulfate in the Subendothelial Extracellular Matrix by a Readily Released Heparanase from Human Neutrophils
    Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. Y Matzner, … , Z Fuks, I Vlodavsky J Clin Invest. 1985;76(4):1306-1313. https://doi.org/10.1172/JCI112104. Research Article Freshly isolated human neutrophils were investigated for their ability to degrade heparan sulfate proteoglycans in the subendothelial extracellular matrix (ECM) produced by cultured corneal and vascular endothelial cells. The ECM was metabolically labeled with Na2(35S)O4 and labeled degradation products were analyzed by gel filtration over Sepharose 6B. More than 90% of the released radioactivity consisted of heparan sulfate fragments 5-6 times smaller than intact heparan sulfate side chains released from the ECM by either papain or alkaline borohydride. These fragments were sensitive to deamination with nitrous acid and were not produced in the presence of either heparin or serine protease inhibitors. In contrast, degradation of soluble high molecular weight heparan sulfate proteoglycan, which was first released from the ECM, was inhibited by heparin but there was no effect of protease inhibitors. These results indicate that interaction of human neutrophils with the subendothelial ECM is associated with degradation of its heparan sulfate by means of a specific, newly identified, heparanase activity and that this degradation is facilitated to a large extent by serine proteases. The neutrophil heparanase was readily and preferentially
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,689,046 B2 Mayall Et Al
    USOO9689046B2 (12) United States Patent (10) Patent No.: US 9,689,046 B2 Mayall et al. (45) Date of Patent: Jun. 27, 2017 (54) SYSTEM AND METHODS FOR THE FOREIGN PATENT DOCUMENTS DETECTION OF MULTIPLE CHEMICAL WO O125472 A1 4/2001 COMPOUNDS WO O169245 A2 9, 2001 (71) Applicants: Robert Matthew Mayall, Calgary (CA); Emily Candice Hicks, Calgary OTHER PUBLICATIONS (CA); Margaret Mary-Flora Bebeselea, A. et al., “Electrochemical Degradation and Determina Renaud-Young, Calgary (CA); David tion of 4-Nitrophenol Using Multiple Pulsed Amperometry at Christopher Lloyd, Calgary (CA); Lisa Graphite Based Electrodes', Chem. Bull. “Politehnica” Univ. Kara Oberding, Calgary (CA); Iain (Timisoara), vol. 53(67), 1-2, 2008. Fraser Scotney George, Calgary (CA) Ben-Yoav. H. et al., “A whole cell electrochemical biosensor for water genotoxicity bio-detection”. Electrochimica Acta, 2009, 54(25), 6113-6118. (72) Inventors: Robert Matthew Mayall, Calgary Biran, I. et al., “On-line monitoring of gene expression'. Microbi (CA); Emily Candice Hicks, Calgary ology (Reading, England), 1999, 145 (Pt 8), 2129-2133. (CA); Margaret Mary-Flora Da Silva, P.S. et al., “Electrochemical Behavior of Hydroquinone Renaud-Young, Calgary (CA); David and Catechol at a Silsesquioxane-Modified Carbon Paste Elec trode'. J. Braz. Chem. Soc., vol. 24, No. 4, 695-699, 2013. Christopher Lloyd, Calgary (CA); Lisa Enache, T. A. & Oliveira-Brett, A. M., "Phenol and Para-Substituted Kara Oberding, Calgary (CA); Iain Phenols Electrochemical Oxidation Pathways”, Journal of Fraser Scotney George, Calgary (CA) Electroanalytical Chemistry, 2011, 1-35. Etesami, M. et al., “Electrooxidation of hydroquinone on simply prepared Au-Pt bimetallic nanoparticles'. Science China, Chem (73) Assignee: FREDSENSE TECHNOLOGIES istry, vol.
    [Show full text]
  • 1994 De Vouge MW, Yamazaki A, Bennett SAL, Chen JH, Shwed PS
    Int. J. Cancer: 56,286-294 (1994) Publication of the International Union Against Cancer Publication de I Union Internattonale Contre le Cancer 0 1994 Wiley-Liss, Inc. a' IMMUNOSELECTION OF GRP94/ENDOPLASMIN FROM A KNRK CELL-SPECIFIC Xgt 11 LIBRARY USING ANTIBODIES DIRECTED AGAINST A PUTATIVE HEPARANASE AMINO-TERMINAL PEPTIDE Michael W. DE VOUGE',Amy YAMAZAKI~,Steffany A.L. BENNETT',Jia-Hua CHEN'4, Philip S. SHWED'2, Chantal COUTURE' and H. Chaim BIRNBOIM1,3 'Ottawa Regional Cancer Centre and University of Ottawa, 501 Smyth Road, Ottawa, Ontario, KlH 8L6, Canada. Induction of an invasive phenotype by metastatic tumour cells Enhanced release of HS fragments from Na2[35S04]-labeled results in part from inappropriate expression of extracellular extracellular matrix was initially correlated with metastatic matrix-degradingenzymes normally involved in embryonic mor- potential in cellular extracts, but not in conditioned media, of phogenesis, tissue remodelling, angiogenesis and wound heal- B16 murine melanoma clones (Nakajima et al., 1983). Analyses ing. Such enzymes include endoglycosidases that degrade hepa- of substrate specificity, and examination of reducing termini of ran sulfate (HS) in endothelial basement membrane, as well as better characterized proteases. Heparanase, an endo-P-D- HS fragments led to the characterization of heparanase as an glucuronidase initially detected in B I6 melanoma cells, has endo-P-D-glucuronidase that is inhibited by heparin (Na- been described as a M, 96 000 glycoprotein with pl of 5.2, and kajima et al.,
    [Show full text]
  • Acid Phosphatase 5 Is Responsible for Removing the Mannose 6-Phosphate Recognition Marker from Lysosomal Proteins
    Acid phosphatase 5 is responsible for removing the mannose 6-phosphate recognition marker from lysosomal proteins Pengling Suna, David E. Sleata, Miche` le Lecocqb, Alison R. Haymanc, Michel Jadotb, and Peter Lobela,1 aCenter for Advanced Biotechnology and Medicine and Department of Pharmacology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, NJ 08854; bLaboratoire de Chimie Physiologique, Unite´de Recherche en Physiologie Mole´culaire, Faculte´s Universitaires Notre-Dame de la Paix, 61 rue de Bruxelles, 5000-Namur, Belgium; and cSchool of Clinical Veterinary Science, University of Bristol, Bristol BS40 5DU, UK Edited by Stuart A. Kornfeld, Washington University School of Medicine, St. Louis, MO, and approved September 12, 2008 (received for review July 31, 2008) Most newly synthesized proteins destined for the lysosome reach Golgi to repeat the process or to the plasma membrane. At the this location via a specific intracellular pathway. In the Golgi, a latter location, the CI-MPR can function in the endocytosis and phosphotransferase specifically labels lysosomal proteins with lysosomal targeting of extracellular Man-6-P glycoproteins. mannose 6-phosphate (Man-6-P). This modification is recognized Early studies indicated that Man-6 phosphorylation was a by receptors that target the lysosomal proteins to the lysosome transient modification of lysosomal proteins that was removed where, in most cell types, the Man-6-P recognition marker is rapidly with a half-life of 1.4 h in mouse lymphoma cells (3) and also removed. Despite extensive characterization of this pathway, the rapidly removed in CHO cells (4). The exact site of dephos- enzyme responsible for the removal of the targeting modification phorylation is not clear, and there is evidence suggesting that it has remained elusive.
    [Show full text]
  • In Vivo Fragmentation of Heparan Sulfate by Heparanase Overexpression Renders Mice Resistant to Amyloid Protein a Amyloidosis
    In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis Jin-Ping Li*†, Martha L. Escobar Galvis*‡, Feng Gong*‡§, Xiao Zhang¶, Eyal Zchariaʈ, Shula Metzger**, Israel Vlodavsky††, Robert Kisilevsky‡‡, and Ulf Lindahl* *Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden; ¶Department of Public Health and Caring Science, Division of Molecular Geriatrics, Rudbeck Laboratory, Uppsala University, Box 609, SE-751 25 Uppsala, Sweden; Departments of ʈOncology and **Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel; ††Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel; and ‡‡Department of Pathology and Molecular Medicine, Queen’s University, Kingston, ON, Canada K7L 3N6 Communicated by D. Carleton Gajdusek, Centre National de la Recherche Scientifique, Gif-sur-Yvette, France, March 21, 2005 (received for review December 22, 2004) Amyloid diseases encompass >20 medical disorders that include The results demonstrate that overexpression of heparanase, amyloid protein A (AA) amyloidosis, Alzheimer’s disease, and type resulting in fragmentation of HS chains, affords protection 2 diabetes. A common feature of these conditions is the selective against amyloidosis. organ deposition of disease-specific fibrillar proteins, along with the sulfated glycosaminoglycan, heparan sulfate. We have gener- Materials and Methods ated transgenic mice that overexpress human heparanase and Animals and Amyloid Induction. The homozygous mouse strain have tested their susceptibility to amyloid induction. Drastic short- overexpressing human heparanase (hpa-tg) and the respective ening of heparan sulfate chains was observed in heparanase- control (ctr) mice (C57BL background) were generated as overproducing organs, such as liver and kidney.
    [Show full text]